Neuroimmune pathophysiology of long COVID
Psychiatry and Clinical Neurosciences · 2025
DOI: 10.1111/pcn.13855 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psychiatry and Clinical Neurosciences, 2025. Verfasst von Janna K Moen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19, Neuroimmunomodulation, Nervous System Diseases, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 342 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Although COVID‐19 was originally considered a respiratory illness, it is now well established that SARS‐CoV‐2 infection can have far‐reaching impacts on the nervous system. Neurological symptoms such as chemosensory dysfunction are frequently observed during acute infection and approximately 10% of COVID‐19 cases will go on to develop new or persistent long‐term symptoms, a condition known in the literature as post‐acute symptoms of COVID‐19 (PASC) or by the patient‐coined term Long COVID. Common neurological symptoms in Long COVID include new onset cognitive difficulties, dysautonomia, fatigue, and peripheral neuropathy. The emergence of Long COVID has prompted renewed interest in the study of post‐acute infection syndromes (PAIS), particularly in the area of neuroimmune interactions. In this review we provide a comprehensive overview of the current body of literature on neurological manifestations of SARS‐CoV‐2 infection and Long COVID, with an emphasis on neuroimmune mechanisms drawn largely from autopsy studies and animal models. A more complete understanding of neuroimmune crosstalk in Long COVID will not only guide the development of therapies for this highly disabling condition but will also contribute to our general understanding of neuroimmune interactions in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
- Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Center for Infection and Immunity, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Janna K Moen, Christopher A Baker, Akiko Iwasaki
Förderung
- Howard Hughes Medical Institute
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Moen, J. K., Baker, C. A., & Iwasaki, A. (2025). Neuroimmune pathophysiology of long COVID. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13855
Vancouver
Moen JK, Baker CA, Iwasaki A. Neuroimmune pathophysiology of long COVID. Psychiatry and Clinical Neurosciences. 2025. doi:10.1111/pcn.13855
BibTeX
@article{Moen2025,
author = {Moen, Janna K and Baker, Christopher A and Iwasaki, Akiko},
title = {Neuroimmune pathophysiology of long COVID},
journal = {Psychiatry and Clinical Neurosciences},
year = {2025},
doi = {10.1111/pcn.13855}
}
EUVIMED